Source:http://linkedlifedata.com/resource/pubmed/id/10477605
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1999-10-4
|
pubmed:abstractText |
Infection of C57BL/6 mice with Toxoplasma gondii leads to chronic encephalitis characterized by infiltration into the brain of T cells that produce IFN-gamma and mediate resistance to the parasite. Our studies revealed that expression of B7.1 and B7.2 was up-regulated in brains of mice with toxoplasmic encephalitis (TE). Because CD28/B7-mediated costimulation is important for T cell activation, we assessed the contribution of this interaction to the production of IFN-gamma by T cells from brains and spleens of mice with TE. Stimulation of splenocytes with Toxoplasma Ag or anti-CD3 mAb resulted in production of IFN-gamma, which was inhibited by 90% in the presence of CTLA4-Ig, an antagonist of B7 stimulation. However, production of IFN-gamma by T cells from the brains of these mice was only slightly reduced (20%) by the addition of CTLA4-Ig. To address the role of the CD28/B7 interaction during TE, we compared the development of disease in C57BL/6 wild-type (wt) and CD28-/- mice. Although the parasite burden was similar in wt and CD28-/- mice, CD28-/- mice developed less severe encephalitis and survived longer than wt mice. Ex vivo recall responses revealed that mononuclear cells isolated from the brains of chronically infected CD28-/- mice produced less IFN-gamma than wt cells, and this correlated with reduced numbers of intracerebral CD4+ T cells in CD28-/- mice compared with wt mice. Taken together, our data show that resistance to T. gondii in the brain is independent of CD28 and suggest a role for CD28 in development of immune-mediated pathology during TE.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
163
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3354-62
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:10477605-Animals,
pubmed-meshheading:10477605-Antigens, CD28,
pubmed-meshheading:10477605-Antigens, CD80,
pubmed-meshheading:10477605-Brain,
pubmed-meshheading:10477605-Chronic Disease,
pubmed-meshheading:10477605-Encephalitis,
pubmed-meshheading:10477605-Female,
pubmed-meshheading:10477605-Immunity, Innate,
pubmed-meshheading:10477605-Mice,
pubmed-meshheading:10477605-Mice, Inbred C57BL,
pubmed-meshheading:10477605-Mice, Inbred CBA,
pubmed-meshheading:10477605-Mice, Knockout,
pubmed-meshheading:10477605-Spleen,
pubmed-meshheading:10477605-T-Lymphocytes,
pubmed-meshheading:10477605-Toxoplasma,
pubmed-meshheading:10477605-Toxoplasmosis, Animal
|
pubmed:year |
1999
|
pubmed:articleTitle |
The CD28/B7 interaction is not required for resistance to Toxoplasma gondii in the brain but contributes to the development of immunopathology.
|
pubmed:affiliation |
Department of Pathobiology, University of Pennsylvania, Philadelphia 19104, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|